ShortedShorted

ORTHOCELL LIMITED ORDINARY (OCC) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
just now

Why Is Orthocell (ASX:OCC) in Focus Over Its Cash Position?

Highlights Orthocell continues maintaining a debt-free balance sheet while advancing regenerative medicine programs. Growing revenue and available cash resources are supporting the company's commercial expansion strategy. Regulatory progress and product commercialisation remain key drivers for the healthcare company. Orthocell Ltd (ASX:OCC) has attracted renewed market attention as its financial position continues supporting the commercial expansion of its regenerativ...

Continue reading
Kalkine
Neutral
just now

Is Orthocell (ASX:OCC) Expanding Its Role in ASX All Ordinaries Biotech Sector?

Highlights Orthocell completes first Remplir procedure in US military hospital network. Healthcare sector activity reflects medical technology adoption and expansion. Market participation highlights integration of biotech companies within ASX indices. Orthocell completes a Remplir procedure in a US military hospital network, highlighting clinical deployment and biotechnology sector participation within ASX All Ordinaries. The healthcare and biotechnology sector represents a significant ...

Continue reading
Kalkine
Neutral
just now

How Orthocell Limited (ASX:OCC) Fits in ASX 300 Healthcare Sector Trends

Highlights Orthocell prepares to release quarterly update and host investor webinar. Biotechnology operations reflect ongoing clinical and commercial activity. Healthcare sector participation continues across Australian equity indices. Orthocell prepares quarterly update and investor webinar, reflecting healthcare sector activity and biotechnology development within Australian equity markets. The healthcare and biotechnology sector remains a key contributor to Australian equity markets,...

Continue reading
Kalkine
Neutral
just now

Orthocell Advances Global Reach with Remplir Success

Highlights Remplir used in real-world surgical settings Global expansion strategy gaining traction Strong financial base supports ongoing growth Orthocell’s Remplir device gains real-world validation through surgical use in demanding environments, strengthening its global expansion strategy and reinforcing its presence across medical and defence-related applications. Orthocell’s Remplir nerve repair device has taken a significant step forward, with its successful application...

Continue reading